Action required: Please refresh your browser
We have recently implemented some changes that require a hard refresh of your browser: Please hold down the CTRL-key and press the F5 key.
After a successful hard refresh, this message should not appear anymore.
More details about this topic are available here »
| Vistin Pharma ASA: Invitation to Q4 2019 conference call | ||
| By: GlobeNewswire - 19 Feb 2020 | Back to overview list |
|
Oslo, Norway, 19 February 2020 Vistin Pharma ASA will release its fourth quarter 2019 results on Friday 28 February 2020. Vistin Pharma will host a conference call for all shareholders and interested parties on 28 February at 08:30 CET. There will be a Q&A session following the management discussion. The conference call will be held in Norwegian. The fourth quarter conference call will be available via web and audio through the following access points: Telephone conference: Webcast: ***** For further information, please contact: Hans Lysheim About Vistin Pharma | www.vistin.com Vistin Pharma is a Norwegian pharmaceutical company producing Metformin Hydrochloride (API). The Metformin is also available as Direct Compressible lubricated granules. As a solely dedicated European Metformin producer, Vistin Pharma is a well-positioned supplier to leading pharmaceutical companies. Vistin Pharma is headquartered in Oslo, Norway, and has highly qualified employees and a dedicated manufacturing facility in Kragerø.
|
||
|
|
||
 | Back to overview list | |